Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 associated thrombotic microangiopathy.
Karabag Yilmaz E, Cebi MN, Karahan I, Saygılı S, Gulmez R, Demirgan EB, Durak C, Aygun F, Ozaltin F, Caliskan S, Canpolat N. Karabag Yilmaz E, et al. Among authors: ozaltin f. Nephrology (Carlton). 2023 Oct;28(10):557-560. doi: 10.1111/nep.14225. Epub 2023 Jul 23. Nephrology (Carlton). 2023. PMID: 37485596
ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.
Korkmaz E, Lipska-Ziętkiewicz BS, Boyer O, Gribouval O, Fourrage C, Tabatabaei M, Schnaidt S, Gucer S, Kaymaz F, Arici M, Dinckan A, Mir S, Bayazit AK, Emre S, Balat A, Rees L, Shroff R, Bergmann C, Mourani C, Antignac C, Ozaltin F, Schaefer F; PodoNet Consortium. Korkmaz E, et al. Among authors: ozaltin f. J Am Soc Nephrol. 2016 Jan;27(1):63-8. doi: 10.1681/ASN.2014121240. Epub 2015 May 12. J Am Soc Nephrol. 2016. PMID: 25967120 Free PMC article.
Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
Azukaitis K, Ju W, Kirchner M, Nair V, Smith M, Fang Z, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Yalcinkaya F, Paripovic D, Harambat J, Cakar N, Alpay H, Lugani F, Mencarelli F, Civilibal M, Erdogan H, Gellermann J, Vidal E, Tabel Y, Gimpel C, Ertan P, Yavascan O, Melk A, Querfeld U, Wühl E, Kretzler M, Schaefer F; 4C Study; ESCAPE Trial Group. Azukaitis K, et al. Kidney Int. 2019 Jul;96(1):214-221. doi: 10.1016/j.kint.2019.01.035. Epub 2019 Mar 20. Kidney Int. 2019. PMID: 31005273 Free article.
COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G, Gulhan B, Atayar E, Saygılı S, Soylemezoglu O, Ozcakar ZB, Eroglu FK, Candan C, Demir BK, Soylu A, Yüksel S, Alpay H, Agbas A, Duzova A, Hayran M, Ozaltin F, Topaloglu R. Ozdemir G, et al. Among authors: ozaltin f. Pediatr Nephrol. 2020 Oct;35(10):1941-1952. doi: 10.1007/s00467-020-04574-8. Epub 2020 May 11. Pediatr Nephrol. 2020. PMID: 32394188
Transplantation in pediatric aHUS within the era of eculizumab therapy.
Özçakar ZB, Ozaltin F, Gülhan B, Çomak E, Parmaksız G, Baskın E, Topaloğlu R, Kasap Demir B, Canpolat N, Yuruk Yildirim Z, Demircioğlu Kılıç B, Yüksel S, Söylemezoğlu O. Özçakar ZB, et al. Among authors: ozaltin f. Pediatr Transplant. 2021 May;25(3):e13914. doi: 10.1111/petr.13914. Epub 2020 Nov 20. Pediatr Transplant. 2021. PMID: 33217100
186 results